England Unveils £680m Innovative Medicines Fund
Bigger Than Had Been Proposed, Fund Extends Cancer Drugs Fund To Other Treatment Areas
Executive Summary
England’s Innovative Medicines Fund is aimed at providing earlier access to promising new treatments, including gene therapies, when further data is needed for routine commissioning.
You may also be interested in...
England’s Innovative Medicines Fund To Put Spotlight On Rare Disease Treatments
While the much-anticipated Innovative Medicines Fund is likely to benefit rare diseases in particular, other products must gain too.
Flexibility Is Key To Making England’s Innovative Medicines Fund Work
Stakeholders are calling for NHS England and NHS Improvement (NHSE&I) and the health technology assessment body NICE to bring more flexibility into England’s new Innovative Medicines Fund, which is due for launch later in 2021.
Expectations Are High But What Precisely Will England’s New IMF Deliver?
The Innovative Medicines Fund, due for launch in England later this year, may provide industry with an opportunity to hold key public bodies to account.